Orthofix International NV Company Profile (NASDAQ:OFIX)

About Orthofix International NV (OFIX)

Orthofix International NV logoOrthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. Its Biologic solutions products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution, VersaShield and Collage Synthetic Osteoconductive Scaffold. Its Extremity Fixation solutions include Fixator, TrueLok, TL-HEX TrueLok Hexapod System, PREFIX and PREFIX 2, Centronail Titanium Nailing System and Galaxy Fixation System. Its Spine Fixation solutions products include Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, ATHLET Vertebral Body Replacement (VBR) System, NGage Surgical Mesh System and PILLAR AL PEEK Partial VBR System.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: OFIX
  • CUSIP: N6748L10
Key Metrics:
  • Previous Close: $38.99
  • 50 Day Moving Average: $37.51
  • 200 Day Moving Average: $38.13
  • 52-Week Range: $32.51 - $48.25
  • Trailing P/E Ratio: 234.88
  • Foreward P/E Ratio: 21.42
  • P/E Growth: 4.02
  • Market Cap: $699.71M
  • Outstanding Shares: 17,946,000
  • Beta: 0.36
Profitability:
  • Net Margins: 2.41%
  • Return on Equity: 9.01%
  • Return on Assets: 6.57%
Debt:
  • Current Ratio: 2.22%
  • Quick Ratio: 1.44%

Analyst Ratings

Consensus Ratings for Orthofix International NV (NASDAQ:OFIX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Orthofix International NV (NASDAQ:OFIX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/18/2015Jefferies Group LLCBoost Price TargetBuy$41.00 -> $48.00N/AView Rating Details
7/10/2015SidotiInitiated CoverageBuy$43.00N/AView Rating Details
(Data available from 3/29/2015 forward)

Earnings

Earnings History for Orthofix International NV (NASDAQ:OFIX)
Earnings by Quarter for Orthofix International NV (NASDAQ:OFIX)
Earnings History by Quarter for Orthofix International NV (NASDAQ:OFIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017        
2/27/2017Q416$0.37$0.42$106.07 million$108.50 millionViewListenView Earnings Details
10/31/2016Q316$0.34$0.36$103.40 million$98.50 millionViewListenView Earnings Details
8/1/2016Q216$0.33$0.41$102.40 million$104.10 millionViewN/AView Earnings Details
4/28/2016Q116$0.15$0.28$93.10 million$98.70 millionViewListenView Earnings Details
2/29/2016Q415$0.23$0.28$102.43 million$104.60 millionViewListenView Earnings Details
11/3/2015Q315$0.13$0.30$96.67 million$101.20 millionViewListenView Earnings Details
8/4/2015Q215$0.09$0.36$96.22 million$101.00 millionViewListenView Earnings Details
5/18/2015Q115$0.08($0.15)$89.50 million$89.80 millionViewListenView Earnings Details
4/29/2015Q414$0.30($0.05)$108.00 million$100.30 millionViewN/AView Earnings Details
3/31/2015$0.22$0.17$95.80 million$101.00 millionViewN/AView Earnings Details
5/7/2014Q1$0.22$0.29$101.10 million$101.34 millionViewN/AView Earnings Details
3/27/2014Q213($0.12)$117.40 million$106.10 millionViewListenView Earnings Details
5/8/2013Q1 2013$0.66$0.23$111.22 million$100.30 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.80$0.81$117.47 million$112.04 millionViewN/AView Earnings Details
10/24/2012$0.74$0.76ViewN/AView Earnings Details
7/26/2012$0.72$0.78ViewN/AView Earnings Details
4/26/2012$0.66$0.69ViewN/AView Earnings Details
2/23/2012$0.73$0.80ViewN/AView Earnings Details
10/27/2011$0.65$0.67ViewN/AView Earnings Details
7/28/2011$0.63$0.69ViewN/AView Earnings Details
5/5/2011$0.55$0.59ViewN/AView Earnings Details
2/15/2011$0.41$0.44ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Orthofix International NV (NASDAQ:OFIX)
Current Year EPS Consensus Estimate: $1.52 EPS
Next Year EPS Consensus Estimate: $1.82 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.17$0.17$0.17
Q2 20161$0.35$0.35$0.35
Q3 20161$0.34$0.34$0.34
Q4 20161$0.37$0.37$0.37
Q1 20171$0.27$0.27$0.27
Q2 20171$0.42$0.42$0.42
Q4 20171$0.40$0.40$0.40
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Orthofix International NV (NASDAQ:OFIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Orthofix International NV (NASDAQ:OFIX)
Insider Ownership Percentage: 5.10%
Institutional Ownership Percentage: 94.23%
Insider Trades by Quarter for Orthofix International NV (NASDAQ:OFIX)
Institutional Ownership by Quarter for Orthofix International NV (NASDAQ:OFIX)
Insider Trades by Quarter for Orthofix International NV (NASDAQ:OFIX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/10/2016Brad MasonCEOSell9,538$36.83$351,284.54View SEC Filing  
9/1/2016Michael FineganInsiderSell25,000$45.16$1,129,000.00View SEC Filing  
6/10/2016Maria SainzDirectorSell4,157$46.33$192,593.81View SEC Filing  
6/9/2016Brad MasonCEOSell18,336$46.00$843,456.00View SEC Filing  
6/8/2016Bradley V NiemannInsiderSell3,402$44.70$152,069.40View SEC Filing  
5/20/2016Robert Allen Goodwin IIInsiderSell13,187$44.00$580,228.00View SEC Filing  
4/18/2016Michael FineganInsiderSell80,972$42.71$3,458,314.12View SEC Filing  
11/11/2015Michael FineganInsiderSell14,140$42.00$593,880.00View SEC Filing  
11/6/2015Brad MasonCEOSell15,018$40.60$609,730.80View SEC Filing  
11/6/2015Jeffrey SchumminsiderSell15,000$40.67$610,050.00View SEC Filing  
6/2/2015Ronald A MatricariaDirectorBuy50,000$32.65$1,632,500.00View SEC Filing  
5/21/2015James F HinrichsDirectorBuy10,000$33.17$331,700.00View SEC Filing  
6/10/2014Mark A HeggestadCFOBuy13,696$33.25$455,392.00View SEC Filing  
5/17/2013Brad MasonCEOBuy5,000$26.45$132,250.00View SEC Filing  
5/17/2013Kenneth R WeisshaarDirectorBuy1,000$26.40$26,400.00View SEC Filing  
5/14/2013James GeroDirectorBuy20,000$26.37$527,400.00View SEC Filing  
2/27/2013Robert S VatersCEOBuy3,000$35.97$107,910.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Orthofix International NV (NASDAQ:OFIX)
Latest Headlines for Orthofix International NV (NASDAQ:OFIX)
Source:
DateHeadline
thestreet.com logo6 Stocks Trading Up With Unusual Volume
www.thestreet.com - March 16 at 8:50 AM
thestreet.com logo6 Stocks Trending Up With Major Volume
www.thestreet.com - March 15 at 9:40 AM
finance.yahoo.com logoOrthofix International (OFIX) Looks Good: Stock Jumps 9.9%
finance.yahoo.com - March 15 at 9:40 AM
finance.yahoo.com logoSynopsys Set to Join S&P 500; The GEO Group to Join S&P MidCap 400; Coca-Cola Bottling and Orthofix International to Join S&P SmallCap 600
finance.yahoo.com - March 13 at 6:43 PM
finance.yahoo.com logoORTHOFIX INTERNATIONAL N V Financials
finance.yahoo.com - March 3 at 7:02 PM
finance.yahoo.com logoEdited Transcript of OFIX earnings conference call or presentation 27-Feb-17 9:30pm GMT
finance.yahoo.com - March 1 at 10:25 AM
reuters.com logoBRIEF-Orthofix International Q4 adjusted EPS $0.42 from continuing operations
www.reuters.com - February 28 at 10:39 AM
biz.yahoo.com logoQ4 2016 Orthofix International NV Earnings Release - After Market Close
us.rd.yahoo.com - February 27 at 5:44 PM
us.rd.yahoo.com logoOrthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results
us.rd.yahoo.com - February 27 at 5:44 PM
finance.yahoo.com logoOrthofix International Schedules Fourth Quarter 2016 and Fiscal Year 2016 Earnings Release and Conference Call for February 27, 2017
finance.yahoo.com - February 16 at 6:35 PM
prnewswire.com logoGlobal Spinal Implants and Devices Market Expected to Reach $13,384 Million by 2022 - Allied Market Research
www.prnewswire.com - February 13 at 9:39 AM
wsj.com logoOrthofix Settles Bribery, Accounting Probes
blogs.wsj.com - February 9 at 1:00 AM
seekingalpha.com logoOrthofix to pay $14M to settle charges of improper revenue recognition and paying bribes to Brazilian doctors
seekingalpha.com - January 20 at 7:48 PM
us.rd.yahoo.com logoOrthofix to pay $14 mln to settle charges it paid off doctors -U.S. SEC
us.rd.yahoo.com - January 19 at 12:38 AM
streetinsider.com logoOrthofix Int'l (OFIX) Confirms SEC Resolution
www.streetinsider.com - January 18 at 7:36 PM
businesswire.com logoOrthofix Announces Resolution of SEC Investigations
www.businesswire.com - January 18 at 7:36 PM
marketwatch.com logoSEC fines Orthofix International $14 million for accounting failures, foreign bribery
www.marketwatch.com - January 18 at 7:36 PM
biz.yahoo.com logoORTHOFIX INTERNATIONAL N V Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - January 18 at 7:36 PM
wsj.com logoOrthofix Settles Bribery, Accounting Probes
blogs.wsj.com - January 18 at 7:36 PM
us.rd.yahoo.com logo8:01 am Orthofix sees Q4 rev above consensus; FY17 rev below consensus, EBITDA margin consistent with FY16
us.rd.yahoo.com - January 11 at 12:55 AM
seekingalpha.com logoOrthofix announces preliminary Q4 and FY2016 net sales results
seekingalpha.com - January 10 at 7:53 PM
finance.yahoo.com logoOrthofix Announces Preliminary 2016 Fourth Quarter and Full Year Net Sales Results
finance.yahoo.com - January 10 at 8:41 AM
biz.yahoo.com logoORTHOFIX INTERNATIONAL N V Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosur
biz.yahoo.com - January 10 at 8:41 AM
streetinsider.com logoOrthofix Int'l (OFIX) Gains FDA and CE Mark Approvals for CervicalStim and SpinalStim Bone Growth Stimulators
www.streetinsider.com - January 9 at 7:42 PM
finance.yahoo.com logoOrthofix Receives FDA and CE Mark Approvals for New Bone Growth Stimulators
finance.yahoo.com - January 9 at 7:42 PM
finance.yahoo.com logo8:07 am Orthofix announces FDA and CE Mark approvals for its CervicalStim and SpinalStim bone growth stimulators
finance.yahoo.com - January 9 at 7:42 PM
finance.yahoo.com logoOFIC NOTICE: Rosen Law Firm Announces Investigation of Securities Claims Against Orthofix International N.V. - OFIX
finance.yahoo.com - January 9 at 7:42 PM

Social

Frequently Asked Questions for Orthofix International NV (NASDAQ:OFIX)

What is Orthofix International NV's stock symbol?

Orthofix International NV trades on the NASDAQ under the ticker symbol "OFIX."

How were Orthofix International NV's earnings last quarter?

Orthofix International NV (NASDAQ:OFIX) released its quarterly earnings data on Monday, February, 27th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.37 by $0.05. The company earned $108.50 million during the quarter, compared to the consensus estimate of $106.07 million. Orthofix International NV had a return on equity of 9.01% and a net margin of 2.41%. The firm's revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.28 earnings per share.

When will Orthofix International NV make its next earnings announcement?

Orthofix International NV is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

What guidance has Orthofix International NV issued on next quarter's earnings?

Orthofix International NV issued an update on its FY17 earnings guidance on Monday, February, 27th. The company provided earnings per share (EPS) guidance of $1.48-1.58 for the period, compared to the Thomson Reuters consensus estimate of $1.68. The company issued revenue guidance of $407-411 million, compared to the consensus revenue estimate of $409.33 million.

Who owns Orthofix International NV stock?

Orthofix International NV's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Camber Capital Management LLC (8.36%), Dimensional Fund Advisors LP (4.26%), Renaissance Technologies LLC (4.18%), Numeric Investors LLC (3.74%), Oakview Capital Management L.P. (2.78%) and State Street Corp (2.04%). Company insiders that own Orthofix International NV stock include Brad Mason, Bradley V Niemann, James F Hinrichs, Jeffrey Schumm, Maria Sainz, Michael Finegan, Robert Allen Goodwin II and Ronald A Matricaria.

Who sold Orthofix International NV stock? Who is selling Orthofix International NV stock?

Orthofix International NV's stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Allianz Asset Management AG, GSA Capital Partners LLP, Guggenheim Capital LLC, Martingale Asset Management L P, Gamco Investors INC. ET AL, AQR Capital Management LLC and Thrivent Financial for Lutherans. Company insiders that have sold Orthofix International NV stock in the last year include Brad Mason, Bradley V Niemann, Maria Sainz, Michael Finegan and Robert Allen Goodwin II.

Who bought Orthofix International NV stock? Who is buying Orthofix International NV stock?

Orthofix International NV's stock was purchased by a variety of institutional investors in the last quarter, including Oakview Capital Management L.P., Renaissance Technologies LLC, Norges Bank, Senzar Asset Management LLC, Russell Investments Group Ltd., Two Sigma Investments LP, Oxford Asset Management and Numeric Investors LLC. Company insiders that have bought Orthofix International NV stock in the last two years include James F Hinrichs and Ronald A Matricaria.

How do I buy Orthofix International NV stock?

Shares of Orthofix International NV can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Orthofix International NV stock cost?

One share of Orthofix International NV stock can currently be purchased for approximately $38.99.

Orthofix International NV (OFIX) Chart for Wednesday, March, 29, 2017

This page was last updated on 3/29/2017 by MarketBeat.com Staff